nortriptyline hydrochloride capsule
preferred pharmaceuticals inc. - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 25 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see error! hyperlink reference not valid. and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated du
allegron nortriptyline (as hydrochloride) 25mg tablet blister pack
arrotex pharmaceuticals pty ltd - nortriptyline, quantity: 25 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; hypromellose; glycerol; maize starch; calcium phosphate; sunset yellow fcf aluminium lake - allegron is indicated for the treatment of major depression.
allegron nortriptyline (as hydrochloride) 10mg tablet blister pack
arrow pharma pty ltd - nortriptyline, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; hypromellose; calcium phosphate; maize starch; glycerol; magnesium stearate - allegron is indicated for the treatment of major depression.
nortriptyline 10mg capsules
kent pharma (uk) ltd - nortriptyline hydrochloride - oral capsule - 10mg
apx-amitriptyline amitriptyline hydrochloride 50 mg tablet blister pack
arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. entrip 50mg tablets are indicated only for the maintenance treatment of major depression (see precautions). nocturnal enuresis where organic pathology has been excluded.
apx-amitriptyline amitriptyline hydrochloride 25 mg tablet blister pack
arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.
apx-amitriptyline amitriptyline hydrochloride 10 mg tablet blister pack
arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.
amitriptyline teva 10 mg
teva israel ltd - amitriptyline hydrochloride - film coated tablets - amitriptyline hydrochloride 10 mg - amitriptyline - amitriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. enuresis nocturna.
sleep assessment device
maskmedic pty ltd - 33843 - sleep assessment device - a device used for the recording of physiological signals from the patient which are typically recorded whilst sleeping and used for assessing sleeping disorders, e.g. snoring or sleep apnoea.
sleep assessment device
excellcare pty ltd - 33843 - sleep assessment device - to be used as a diagnostic tool in the medical management of sleep-related breathing disorders. can be used in the diagnosis of myocardial ischemia and endothelium dysfunctions. to be worn on the wrist by the patient at home while they sleep along with a non-invasive finger mounted pneu-optical probe to measure the peripheral arterial tonometry (pat) signal. in addition to the pat signal, oxygen saturation, actigraphy (body movement), pulse rate, body position and snoring (db) are also recorded and stored on the device from which the recorded signals can be downloaded to a computer for automatic analysis and reporting utilising proprietary algorithams. can provide analysis of respiratory disturbance, apnea-hypopnea, endothelia function, oxygen desaturation, rem/nrem sleep stages, light/deep sleep stages, sleep/wake states, heart rate, oxygen saturation level, body position and snoring.